Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

      Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

      Farhat Nasim29 April 2019 4:05 AM
      The positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
      Roche withdraws refiling of Premerger Notification, Report Form under the HSR Act

      Roche withdraws refiling of Premerger Notification, Report Form under the HSR Act

      Farhat Nasim28 April 2019 4:15 AM
      Roche has elected to withdraw and refile the Premerger Notification and Report Form under the HSR Act.New Delhi: Roche and Spark Therapeutics, Inc....
      JnJ Faulty Hip Implants Case: Mumbai police reopens investigation

      JnJ Faulty Hip Implants Case: Mumbai police reopens investigation

      Farhat Nasim27 April 2019 9:30 AM
      New Delhi: Embroiled in controversies, Johnson and Johnson Pvt. Ltd (JnJ) is likely to face another impending challenge as the Mumbai cops have...
      Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report

      Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report

      Farhat Nasim26 April 2019 8:50 AM
      New Delhi: Sun Pharmaceutical (Sun Pharma) Industries Ltd's Dadra plant has reportedly received 11 observations, "serious" in nature from the U.S....
      Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

      Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

      Farhat Nasim26 April 2019 7:19 AM
      Leflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
      Torrent Pharma gets certain USFDA observations for Indrad plant

      Torrent Pharma gets certain USFDA observations for Indrad plant

      Farhat Nasim26 April 2019 4:30 AM
      The audit at Indrad plant of Torrent Pharma was carried out by the United States Food and Drug Administration (USFDA) in April. New Delhi: Drug firm...
      Glenmark gets Russian Healthcare Ministry nod for nasal spray Momate Rhino

      Glenmark gets Russian Healthcare Ministry nod for nasal spray Momate Rhino

      Farhat Nasim26 April 2019 4:00 AM
      The approval to market Momate Rhino as an OTC product paves way for the company to widen patient accessibility of this medicine, which is particularly...
      Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

      Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

      Farhat Nasim25 April 2019 5:20 AM
      The approved product Estradiol Vaginal Inserts USP, 10 mcg is a generic version of Novo Nordisk Inc's VAGIFEM. New Delhi: Glenmark Pharmaceuticals has...
      Monarch eTNS: First medical device for treating ADHD gets USFDA approval

      Monarch eTNS: First medical device for treating ADHD gets USFDA approval

      Farhat Nasim25 April 2019 4:29 AM
      The first medical device for treating ADHD, Monarch eTNS system's efficacy in treating ADHD was demonstrated in a clinical trial wherein they compared...
      Indoco Remedies: USFDA retains OAI status for Goa plant

      Indoco Remedies: USFDA retains OAI status for Goa plant

      Farhat Nasim25 April 2019 4:20 AM
      Indoco Remedies' spokesperson said that the move is likely to withhold approval of pending abbreviated new drug applications (ANDAs) from Goa...
      Novartis mulling $1.5 million-$5 million price range for gene therapy Zolgensma

      Novartis mulling $1.5 million-$5 million price range for gene therapy Zolgensma

      Farhat Nasim25 April 2019 4:15 AM
      U.S. regulators are due to make a decision on approving Novartis' Zolgensma next month.ZURICH: Novartis Chief Executive Vas Narasimhan said on...
      Sole Bidder of SevenHills Hospital to restart operations, gets NCLT tribunal nod

      Sole Bidder of SevenHills Hospital to restart operations, gets NCLT tribunal nod

      Farhat Nasim24 April 2019 12:01 PM
      Mumbai: The fate of SevenHills Hospital has finally been pronounced as the National Company Law Tribunal (NCLT) has ruled in favour of BR Shetty, the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok